Earlier in the day, the National Technical Advisory Group on Immunisation (NTAGI) recommended an increase in the gap between two doses of Serum Institute of India’s COVISHIELD to 12-16 weeks.
However, no such changes were recommended in the intervals of Bharat Biotech’s COVAXIN.
Sources said, “The National Technical Advisory Group on Immunisation (NTAGI) recommends for increasing gap between two doses of COVISHIELD to 12-16 weeks. No change in interval of COVAXIN.”
Source link